Verpora's webinar series exploring the latest trends and policies surrounding Global Innovative Contracting and Value Based Agreements. Providing insight from industry experts with real-world experiences in successfully implementing Global Innovative Contracting and interactive discussion of policy considerations.
This webinar provides an overview of some of the latest examples of innovative contracting in the pharmaceutical industry, and highlights new case studies and pilot projects. Our summary addresses…
Emerging Trends in Innovative Contracting
Our experts discuss the increased use of digital technologies, patient-centric approaches, the growth of value-based agreements and other new industry trends, and provide an update on any new regulatory developments related to innovative contracting in pharmaceuticals.
Policy & Legislative Updates
Any new regulatory developments related to innovative contracting in pharmaceuticals, and highlights any changes or updates to existing regulations or any new guidance that has been released.
Recent News & Events
To keep you up-to-date and informed on industry developments, our panel will summarise notable news or events, such as new partnerships or collaborations, mergers and acquisitions, or industry-wide initiatives.
The webinar concludes with a Q&A session, allowing for questions from participants about any of the updates and developments presented in the webinar.
Register Now
This webinar is free of charge. Places are limited to ensure high-quality interactive discussion.
UK / Europe / Asia Webinar Session
New Date: Thursday 16 January 2025
08:30 - 09:00 GMT
09:30 Europe / 16:30 China
/ 17:30 Japan, Korea & Australia
Update and Overview of Global Trends in Innovative Contracting
Verpora will share an analysis of the types of innovative contracts implemented in various markets spanning the globe and payer archetypesInnovative Contract Case Study: Denmark
Our experts examine the tiered pricing solution implemented by Roche for Evrysdi; the first SMA treatment to unlock access in patients over 25 years oldAntimicrobial Product Subscription Model: UK
In the wake of the COVID pandemic, the focus on public health threats has been heightened. Find out how the UK NHS is looking to a subscription model to incentivise antimicrobial innovationYour questions
You are welcome to submit your Innovative Contracting questions for our experts during registration, or at any point in the run-up towards the live webinar. Email questions to communications@verpora.com
USA Webinar Session
New Date: Thursday 16 January 2025
16:30 - 17:00 GMT
11:30 EST / 10:30 CST / 08:30 PST
Update and Overview of Global Trends in Innovative Contracting
Verpora will share an analysis of the types of innovative contracts implemented in various markets spanning the globe and payer archetypesGLP1s : How Innovative Contracting is being used to overcome GLP-1 access barriers
Our experts outline the payer and pharma challenges posed by the GLP-1 therapies and the initial types of innovative contracts being deployed in the US to help overcome these challengesInnovative Contract Case Study: Dupixent
Medicaid recently entered into a value-based agreement for Sanofi's Dupixent., which is approved in multiple indications. Join us to learn more.Your questions
You are welcome to submit your Innovative Contracting questions for our experts during registration, or at any point in the run-up towards the live webinar. Email questions to communications@verpora.com
This webinar is open exclusively to employees of pharmaceutical and medical technology organizations…
Market access and pricing professionals
Global / Regional / National account directors interested
in Innovative ContractingPharmaceutical executives
Representing Verpora
Speaker
Omar Ali
Head of Payers, Verpora
It takes a payer to know a payer’s mind, and Omar’s long experience puts him in an ideal position to unlock critical payer insights. A previous pharmacy & therapeutics payer and adviser to the UK national HTA appraisal body NICE, Omar’s experience encompasses the managed entry of new medicines and health technology appraisals with a deep knowledge of market access, pricing, reimbursement and health economics. For Verpora, Omar manages a global team of experienced pharmacy payers who bring in-depth insights to product value propositions and validation of market access strategy across international launch sequence portfolios. Omar is presently studying for his PhD in Value-Based Contracting.
Speaker
Adam Buckler
VP Innovative Contracting, Verpora
Adam Buckler is an experienced pharmacist with over 12 years of NHS experience in acute Trusts and at The Royal Marsden NHS Foundation Trust, a renowned oncology and haematology center. With a focus on Electronic Prescribing & Medicines Administration (EPMA) and Education & Training (E&T), Adam has developed expertise in NHS data systems, capabilities, and processes. He has contributed to the NHSE and NIHR Electronic-Prescribing Toolkit. At Verpora, Adam leads Innovative Contracting consultancy projects, client contracting capability build programs, and provides valuable clinical and healthcare expertise to the VSTx product. He is a certified member of the BHBIA and registered with the GPhC.
Host
Wanda Lesowiec
VP Commercial Accounts, Verpora
Wanda is an experienced Market Manager with a history of success in the pharmaceutical and medical device industry.
Bringing an understanding of the requirements of Pharmaceutical and Medical device companies and especially the challenges faced in Market Access, Wanda will be consolidating and building on the Verpora’s strong track record as a global specialist consultancy in the field of innovative and value-based contracting.
Register Now
This webinar is free of charge. Places are limited to ensure high-quality interactive discussion.
UK / Europe / Asia Webinar Session
New Date: Thursday 16 January 2025
08:30 - 09:00 GMT
09:30 Europe / 16:30 China
/ 17:30 Japan, Korea & Australia
USA Webinar Session
New Date: Thursday 16 January 2025
16:30 - 17:00 GMT
11:30 EST / 10:30 CST / 08:30 PST